MicroSert Israeli Company

MicroSert develops an easily implantable, refillable, reservoir-type device for long-lasting ocular drug release. The device is capable of sustained and controlled release of biologic medications and can be refilled for up to two years after being implanted. MicroSert intends to further develop this versatile drug-delivery platform for the treatment of age-related macular degeneration and diabetic macular edema.